Haim–Munk syndrome
| Haim–Munk syndrome | |
|---|---|
| Synonyms | Cochin Jewish disorder |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Palmoplantar keratoderma, periodontitis, onychogryphosis, acral osteolysis |
| Complications | Tooth loss, bone resorption |
| Onset | Childhood |
| Duration | Lifelong |
| Types | |
| Causes | Genetic mutation in the CTSC gene |
| Risks | |
| Diagnosis | Genetic testing, clinical examination |
| Differential diagnosis | Papillon–Lefèvre syndrome, Mal de Meleda |
| Prevention | |
| Treatment | Retinoids, antibiotics, dental care |
| Medication | |
| Prognosis | Variable, depends on management of symptoms |
| Frequency | Rare |
| Deaths | |
Haim–Munk syndrome (HMS) is a rare autosomal recessive genetic disorder characterized by a combination of palmoplantar keratoderma, periodontitis, onychogryphosis, and acral osteolysis. It is named after the physicians Seymour Haim and J. Munk, who first described the condition.
Clinical Features[edit]
Haim–Munk syndrome presents with several distinctive clinical features:
- Palmoplantar keratoderma: Thickening of the skin on the palms of the hands and the soles of the feet.
- Periodontitis: Severe inflammation of the gums leading to early loss of teeth.
- Onychogryphosis: Abnormal curvature and thickening of the nails.
- Acral osteolysis: Bone resorption in the distal phalanges, leading to shortening of the fingers and toes.
Genetics[edit]
Haim–Munk syndrome is inherited in an autosomal recessive manner. The condition is caused by mutations in the CTSC gene, which encodes the enzyme cathepsin C. This enzyme is crucial for the activation of certain proteases involved in the immune response and skin integrity.
Diagnosis[edit]
Diagnosis of Haim–Munk syndrome is based on clinical evaluation, family history, and genetic testing to identify mutations in the CTSC gene. Differential diagnosis includes other conditions with similar features, such as Papillon–Lefèvre syndrome.
Treatment[edit]
There is no cure for Haim–Munk syndrome. Treatment focuses on managing symptoms and may include:
- Regular dental care to manage periodontitis.
- Use of emollients and keratolytic agents for palmoplantar keratoderma.
- Surgical intervention for severe onychogryphosis.
- Monitoring and management of bone resorption in cases of acral osteolysis.
Prognosis[edit]
The prognosis for individuals with Haim–Munk syndrome varies. Early diagnosis and management of symptoms can improve the quality of life, but the condition can lead to significant morbidity due to dental issues and skin problems.
Related Pages[edit]
- Autosomal recessive
- Genetic disorder
- Palmoplantar keratoderma
- Periodontitis
- Onychogryphosis
- Acral osteolysis
- CTSC gene
- Papillon–Lefèvre syndrome
See Also[edit]

This article is a genetic disorder stub. You can help WikiMD by expanding it!
Ad. Transform your life with W8MD's
GLP-1 weight loss injections special from $29.99 with insurance
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian